Loading...

Kailera Therapeutics, Inc.

KLRANASDAQ
NaN
NaN
$25.22
$0.61(2.48%)
U.S. Market opens in 3h 41m

Kailera Therapeutics, Inc. (KLRA) Stock Competitors & Peer Comparison

See (KLRA) competitors and their performances in Stock Market.

Peer Comparison Table: NaN Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
KLRA$25.22+2.48%840.7M-20.02-$1.26N/A
ILMNV$107.00+1.66%17BN/AN/AN/A
SHAPX$35.63-1.14%9B29.23$1.23N/A
QLENX$19.43-1.67%8BN/AN/AN/A
DFFGX$9.97+0.00%1.8BN/AN/AN/A
TAOZ$85.99+0.00%467.2MN/AN/AN/A
RMIX$12.91+2.01%302.4M33.97$0.38N/A
DRLL$35.65+1.77%267.4M20.32$1.75+1.18%
ALMR$23.22+5.55%217.7M-51.60-$0.45N/A
GDIV$17.84-0.53%208M26.09$0.68+1.17%
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

KLRA vs ILMNV Comparison April 2026

KLRA plays a significant role within the NaN sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, KLRA stands at 840.7M. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, KLRA is priced at $25.22, while ILMNV trades at $107.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

KLRA currently has a P/E ratio of -20.02, whereas ILMNV's P/E ratio is N/A. In terms of profitability, KLRA's ROE is N/A, compared to ILMNV's ROE of N/A. Regarding short-term risk, KLRA is more volatile compared to ILMNV. This indicates potentially higher risk in terms of short-term price fluctuations for KLRA.Check ILMNV's competition here

Stock price comparison of stocks in the NaN Sector

Loading...

Frequently Asked Questions